In contrast to the rosy top-line, the data are potentially showing a troubling trendline.
The number of new biotech startups announcing their first rounds of funding has dropped each quarter since beginning of 2019, down nearly 50% from a year ago, to what may be the lowest number in five years.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,